ZIC
RXII

ZWJ Investment Counsel’s GALENA BIOPHARMA INC COM RXII Stock Holding History

ZWJ Investment Counsel’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,000
Closed -$50K – 146
2013
Q4 		$50K Hold
10,000
– – 0.01% 137
2013
Q3 		$23K Hold
10,000
– – ﹤0.01% 128
2013
Q2 		$22K Buy
+10,000
New +$22K ﹤0.01% 137

Other funds holding RXII

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ZWJ Investment Counsel's RXII Position: Q1 2014 in Review

ZWJ Investment Counsel sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2014, closing a stake of 10,000 shares — an estimated $50K sold.

ZWJ Investment Counsel first reported a position in RXII in Q2 2013 and held it in 3 quarters. The position peaked at $50K in Q4 2013. 88 funds tracked by Wall St. Rank hold RXII as of Q1 2014.

  • ZWJ Investment Counsel reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2014 after selling out during the quarter.
  • ZWJ Investment Counsel sold 10,000 GALENA BIOPHARMA INC COM shares in Q1 2014, an estimated $50K.
  • ZWJ Investment Counsel first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 3 quarters.
  • ZWJ Investment Counsel's GALENA BIOPHARMA INC COM position peaked at $50K in Q4 2013.
  • 88 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2014.

Based on ZWJ Investment Counsel's 13F filing for Q1 2014, filed 13 May 2014.